145 related articles for article (PubMed ID: 9780708)
1. [Recent progress in the drug therapy for gastrointestinal bleeding].
Nakajima S; Bamba T
Nihon Rinsho; 1998 Sep; 56(9):2291-6. PubMed ID: 9780708
[TBL] [Abstract][Full Text] [Related]
2. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.
Khuroo MS; Khuroo MS; Farahat KL; Kagevi IE
J Gastroenterol Hepatol; 2005 Jan; 20(1):11-25. PubMed ID: 15610441
[TBL] [Abstract][Full Text] [Related]
3. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
Uedo N; Takeuchi Y; Yamada T; Ishihara R; Ogiyama H; Yamamoto S; Kato M; Tatsumi K; Masuda E; Tamai C; Yamamoto S; Higashino K; Iishi H; Tatsuta M
Am J Gastroenterol; 2007 Aug; 102(8):1610-6. PubMed ID: 17403076
[TBL] [Abstract][Full Text] [Related]
4. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
5. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
Keyvani L; Murthy S; Leeson S; Targownik LE
Aliment Pharmacol Ther; 2006 Oct; 24(8):1247-55. PubMed ID: 17014584
[TBL] [Abstract][Full Text] [Related]
6. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
7. The role of acid suppressants in upper gastrointestinal ulcer bleeding.
van Leerdam ME; Rauws EA
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):463-75. PubMed ID: 11403539
[TBL] [Abstract][Full Text] [Related]
8. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding.
Mohamed SA; al Karawi MA
Hepatogastroenterology; 1996; 43(10):863-5. PubMed ID: 8884305
[TBL] [Abstract][Full Text] [Related]
10. The role of proton pump inhibitors in the management of upper gastrointestinal bleeding.
Leontiadis GI; Howden CW
Gastroenterol Clin North Am; 2009 Jun; 38(2):199-213. PubMed ID: 19446254
[TBL] [Abstract][Full Text] [Related]
11. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
Gostishchev VK; Evseev MA
Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
[TBL] [Abstract][Full Text] [Related]
12. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
Geus WP
Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
[TBL] [Abstract][Full Text] [Related]
13. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
14. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
15. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
16. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
[TBL] [Abstract][Full Text] [Related]
17. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole to prevent recurrent bleeding after endoscopic treatment of ulcers.
Libby ED
N Engl J Med; 2000 Aug; 343(5):358-9. PubMed ID: 10922427
[No Abstract] [Full Text] [Related]
19. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses.
Andriulli A; Annese V; Caruso N; Pilotto A; Accadia L; Niro AG; Quitadamo M; Merla A; Fiorella S; Leandro G
Am J Gastroenterol; 2005 Jan; 100(1):207-19. PubMed ID: 15654802
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the therapeutic effects and acid suppression of H2-receptor antagonist and proton pump inhibitor in patients with gastric body ulcer--a prospective controlled trial].
Takeyama Y; Matsui T; Yao T; Motomura A; Arita M; Okada M; Tanaka K; Imamura T; Hatakeyama S
Nihon Shokakibyo Gakkai Zasshi; 1999 May; 96(5):502-10. PubMed ID: 10368993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
